The effects of a nurse run clinic on the quality of life of children with atopic eczema and the impact of the disease on their families

Completed

• Conditions: Skin and connective tissue diseases; Skin and Connective Tissue Diseases; Atopic dermatitis

• Registration Number: ISRCTN84190054
• Lead Sponsor: HS R&D Regional Programme Register - Department of Health (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2004-01-23
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 235

Inclusion Criteria

1. Age 6 months up to 16th birthday
2. Diagnosis of atopic eczema made using British Association of Dermatology guidelines
3. New cases and patients requesting repeat prescription for medication issued for a diagnosis of atopic eczema.

Exclusion Criteria

1. Poorly controlled asthma defined as patient receiving oral steroids or having a change in dose of medication in the 4 weeks prior to recruitment (children with stable asthma will be included).
2. Children from the same family of a child who has already participated in the trial (to eliminate the risk of contamination of intervention and control groups).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quality of life will be assessed using validated instruments: <br>1. Family Impact Questionnaire (FIQ). <br>2. Infant Eczema Life Quality Index questionnaire (IELQI) for children aged 6 months to 4 years. <br>3. Children's Dermatology Life Quality Index Questionnaire (CDLQI) for children aged 4-16. <br>4. Change in the Family Dermatitis Index (FDI), Infants Eczema Life Quality Index (IELQI) and Children's Dermatology Life Quality Index (CDLQI) recorded at baseline and at 4 weeks and 12 weeks post-intervention.

Secondary Outcome Measures

Name	Time	Method
ot provided at time of registration